Pedersen E B, Danielsen H, Spencer E S
Eur J Clin Pharmacol. 1984;26(5):543-7. doi: 10.1007/BF00543482.
Renal plasma flow (RPF), glomerular filtration rate (GFR), arginine vasopressin in plasma (AVP), free water clearance (CH2O) and blood pressure (BP) were determined in 11 patients with essential hypertension at the end of 3 consecutive periods of observation each of 6 of weeks duration; indapamide 2.5 mg daily was given in period 2 and placebo in periods 1 and 3. RPF and GFR were reduced by 9% and BP by 9%/14% supine and 14%/12% standing during indapamide treatment. Changes in renal haemodynamics were not correlated with those in BP. AVP was not significantly altered by indapamide and was not correlated with BP. Indapamide reduced CH2O possibly due to the reduction in GFR. It is concluded that indapamide evidently induces redistribution of the cardiac output, with enhanced muscle blood flow and reduced renal perfusion, and that AVP does not seem to be involved in blood pressure regulation in mild to moderate essential hypertension under basal conditions.
在11例原发性高血压患者中,在连续3个观察期(每个观察期持续6周)结束时测定了肾血浆流量(RPF)、肾小球滤过率(GFR)、血浆精氨酸加压素(AVP)、自由水清除率(CH2O)和血压(BP);第2期给予吲达帕胺每日2.5 mg,第1期和第3期给予安慰剂。在吲达帕胺治疗期间,RPF和GFR降低了9%,BP仰卧位降低了9%/14%,站立位降低了14%/12%。肾血流动力学的变化与BP的变化无关。吲达帕胺对AVP无显著影响,且与BP无关。吲达帕胺降低了CH2O,可能是由于GFR降低所致。结论是,吲达帕胺明显引起心输出量重新分布,肌肉血流增加而肾灌注减少,并且在基础条件下,AVP似乎不参与轻度至中度原发性高血压的血压调节。